Microbiota Regulate Intestinal Epithelial Gene Expression by Suppressing the Transcription Factor Hepatocyte Nuclear Factor 4 Alpha
Overview
Authors
Affiliations
Microbiota influence diverse aspects of intestinal physiology and disease in part by controlling tissue-specific transcription of host genes. However, host genomic mechanisms mediating microbial control of intestinal gene expression are poorly understood. Hepatocyte nuclear factor 4 (HNF4) is the most ancient family of nuclear receptor transcription factors with important roles in human metabolic and inflammatory bowel diseases, but a role in host response to microbes is unknown. Using an unbiased screening strategy, we found that zebrafish Hnf4a specifically binds and activates a microbiota-suppressed intestinal epithelial transcriptional enhancer. Genetic analysis revealed that zebrafish activates nearly half of the genes that are suppressed by microbiota, suggesting microbiota negatively regulate Hnf4a. In support, analysis of genomic architecture in mouse intestinal epithelial cells disclosed that microbiota colonization leads to activation or inactivation of hundreds of enhancers along with drastic genome-wide reduction of HNF4A and HNF4G occupancy. Interspecies meta-analysis suggested interactions between HNF4A and microbiota promote gene expression patterns associated with human inflammatory bowel diseases. These results indicate a critical and conserved role for HNF4A in maintaining intestinal homeostasis in response to microbiota.
Ballerini M, Galie S, Tyagi P, Catozzi C, Raji H, Nabinejad A Nat Biomed Eng. 2025; .
PMID: 39939548 DOI: 10.1038/s41551-024-01318-z.
A whole-animal phenotypic drug screen identifies suppressors of atherogenic lipoproteins.
Kelpsch D, Zhang L, Thierer J, Koren K, Kumar U, Lin Y bioRxiv. 2024; .
PMID: 39605440 PMC: 11601432. DOI: 10.1101/2024.11.14.623618.
Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies.
Kelly C, Sartor R, Rawls J Am J Physiol Gastrointest Liver Physiol. 2024; 328(1):G17-G31.
PMID: 39499254 PMC: 11901386. DOI: 10.1152/ajpgi.00252.2024.
Fu C, Zhao Y, Zhou X, Lv J, Jin S, Zhou Y Front Immunol. 2024; 15:1395580.
PMID: 39399486 PMC: 11466805. DOI: 10.3389/fimmu.2024.1395580.
Ma Z, Zuo T, Frey N, Rangrez A Signal Transduct Target Ther. 2024; 9(1):237.
PMID: 39307902 PMC: 11418828. DOI: 10.1038/s41392-024-01946-6.